11 studies found for:    "Papilledema"
Show Display Options
RSS Create an RSS feed from your search for:
"Papilledema"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Suspended Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention:
2 Recruiting Antiacne Medications Pseudotumor Cerebri
Condition: Optic Disc Swelling
Intervention: Other: Retinal nerve fibre layer measurement
3 Completed Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Conditions: Uveitis;   Glaucoma
Intervention:
4 Active, not recruiting Ozurdex for Macular Edema Post Membrane Peeling
Conditions: Epiretinal Membrane;   Cellophane Maculopathy;   Macular Edema;   Retinal Edema
Interventions: Drug: Dexamethasone;   Drug: dexamethasone
5 Completed
Has Results
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen® pegaptanib sodium
6 Recruiting Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Conditions: Cataract;   Retinal Edema;   Inflammation
Interventions: Drug: Prolensa (bromfenac 0.07%);   Drug: Ilevro (nepafenac 0.3%)
7 Unknown  A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen (Pegaptanib Sodium)
8 Withdrawn Disc Edema in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
9 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
10 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
11 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:

Indicates status has not been verified in more than two years